Search Results - Fielding, Adele
- Showing 1 - 20 results of 43
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Antibody responses to SARS‐CoV‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies by Chan, Wei Yee, Zhu, Catherine, Sanchez, Emilie, Gupta, Rajeev, Fielding, Adele K., Khwaja, Asim, Payne, Elspeth M., O'Nions, Jenny
Published 2022Text -
9
Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus by Aref, Sarah, Castleton, Anna Z., Bailey, Katharine, Burt, Richard, Dey, Aditi, Leongamornlert, Daniel, Mitchell, Rachel J., Okasha, Dina, Fielding, Adele K.
Published 2020Text -
10
Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights by Patel, Bella, Dey, Aditi, Ghorani, Ehsan, Kumar, Shaji, Malam, Yogeshkumar, Rai, Lena, Steele, Andrew J, Thomson, Jennifer, Wickremasinghe, R Gitendra, Zhang, Yu, Castleton, Anna Z, Fielding, Adele K
Published 2011Text -
11
Single nucleotide polymorphism array‐based signature of low hypodiploidy in acute lymphoblastic leukemia by Creasey, Thomas, Enshaei, Amir, Nebral, Karin, Schwab, Claire, Watts, Kathryn, Cuthbert, Gavin, Vora, Ajay, Moppett, John, Harrison, Christine J., Fielding, Adele K., Haas, Oskar A., Moorman, Anthony V.
Published 2021Text -
12
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology by Patel, Bella, Dey, Aditi, Castleton, Anna Z., Schwab, Claire, Samuel, Edward, Sivakumaran, Janani, Beaton, Brendan, Zareian, Nahid, Zhang, Christie Yu, Rai, Lena, Enver, Tariq, Moorman, Anthony V., Fielding, Adele K.
Published 2014Text -
13
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity by Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Salek, Sam
Published 2020Text -
14
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study by Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Salek, Sam
Published 2020Text -
15
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3‐mutated acute myeloid leukaemia and severe COVID‐19 by Wilson, Andrew J., Troy‐Barnes, Ethan, Subhan, Maryam, Clark, Fiona, Gupta, Rajeev, Fielding, Adele K., Kottaridis, Panagiotis, Mansour, Marc R., O'Nions, Jenny, Payne, Elspeth, Chavda, Naina, Baker, Robert, Thomson, Kirsty, Khwaja, Asim
Published 2020Text -
16
Outcomes In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC UKALL XII/ECOG2993 Trial by Sive, Jonathan I., Buck, Georgina, Fielding, Adele, Lazarus, Hillard M., Litzow, Mark R., Luger, Selina, Marks, David I., McMillan, Andrew, Moorman, Anthony V., Richards, Susan M., Rowe, Jacob M., Tallman, Martin S., Goldstone, Anthony H.
Published 2012Text -
17
Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Tra... by Kumar, Anita J., Gimotty, Phyllis A., Gelfand, Joel, Buck, Georgina, Rowe, Jacob M., Goldstone, Anthony H, Fielding, Adele, Marks, David I, Litzow, Mark, Paietta, Elisabeth, Lazarus, Hillard M., Tallman, Martin S., Luger, Selina M., Loren, Alison W.
Published 2016Text -
18
Characterisation of the genomic landscape of CRLF2‐rearranged acute lymphoblastic leukemia by Russell, Lisa J., Jones, Lisa, Enshaei, Amir, Tonin, Stefano, Ryan, Sarra L., Eswaran, Jeyanthy, Nakjang, Sirintra, Papaemmanuil, Elli, Tubio, Jose M. C., Fielding, Adele K., Vora, Ajay, Campbell, Peter J., Moorman, Anthony V., Harrison, Christine J.
Published 2017Text -
19
Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia by Gökbuget, Nicola, Kantarjian, Hagop M., Brüggemann, Monika, Stein, Anthony S., Bargou, Ralf C., Dombret, Hervé, Fielding, Adele K., Heffner, Leonard, Rigal-Huguet, Françoise, Litzow, Mark, O’Brien, Susan, Zugmaier, Gerhard, Gao, Shan, Nagorsen, Dirk, Forman, Stephen J., Topp, Max S.
Published 2019Text -
20
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study by Goswami, Pushpendra, Oliva, Esther N., Ionova, Tatyana, Else, Roger, Kell, Jonathan, Fielding, Adele K., Jennings, Daniel M., Karakantza, Marina, Al-Ismail, Saad, Collins, Graham P., McConnell, Stewart, Langton, Catherine, Al-Obaidi, Magda J., Oblak, Metod, Salek, Sam
Published 2020Text